Device Trial Radar · NCT02993211
Transurethral En Bloc Versus Standard Resection of Bladder Tumour
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
350
Actual
Start
Apr 18, 2017
Primary completion
Feb 11, 2022
Study completion Jun 9, 2022
Sponsor
- Lead sponsor
- Chinese University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Kwong Wah Hospital; North District Hospital; Our Lady of Maryknoll Hospital; Pok Oi Hospital; The University of Hong Kong; Tseung Kwan O Hospital, Hong Kong; Tuen Mun Hospital; Tung Wah Hospital; United Christian Hospital; Princess Margaret Hospital, Hong Kong; Caritas Medical Centre, Hong Kong; Queen Elizabeth Hospital, Hong Kong
- First posted
- Dec 15, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Conventionally, transurethral standard resection (SR) of bladder tumour is performed in a piecemeal manner. Transurethral en bloc resection (EBR) has been described as an alternate surgical technique in bladder tumour resection. By preventing tumour fragmentation and ascertaining complete tumour resection by histological assessment of the EBR specimen, we hypothesized that EBR could reduce disease recurrence as compared to SR.
Conditions
- Bladder Cancer
Interventions
Bipolar transurethral standard resectionDevice
Olympus TURis Bipolar HF-resection electrode (Model: WA22306D)
Bipolar transurethral en bloc resectionDevice
Olympus TURis Bipolar HF-resection electrode (Model: WA22306D)
Primary outcomes
What the sponsor says the trial is designed to measure.
- One-year recurrence rateTime frame: One year after the allocated treatment
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Caritas Medical Centre
Hong Kong, Hong Kong
Kwong Wah Hospital
Hong Kong, Hong Kong
North District Hospital
Hong Kong, Hong Kong
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.